Equities researchers at StockNews.com initiated coverage on shares of Calithera Biosciences (NASDAQ:CALA – Get Free Report) in a research report issued on Monday. The brokerage set a “hold” rating on the biotechnology company’s stock.
Calithera Biosciences Price Performance
The business’s 50 day simple moving average is $0.01 and its 200-day simple moving average is $0.01. Calithera Biosciences has a 52 week low of $0.00 and a 52 week high of $0.12.
Calithera Biosciences Company Profile
Featured Stories
- Five stocks we like better than Calithera Biosciences
- Insider Trades May Not Tell You What You Think
- Beyond NVIDIA: Top 5 Semiconductor Stocks to Watch for 2025
- P/E Ratio Calculation: How to Assess Stocks
- Netflix Is On Track To Hit $1,000 By Christmas
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- UMAC Stock Climbs Amid Trump Jr. Appointment and Meme Stock Hype
Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
